Abdullah Saleh Al-Wajeeh

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsHaematologyMining engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 28, 2023
Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway.

Futoon Abedrabbu Al-Rawashde, Ola M Al-Sanabra, Moath Alqaraleh

|Apr 13, 2023
HBB Gene Mutations and Their Pathological Impacts on HbE/β-Thalassaemia in Kuala Terengganu, Malaysia.

Hanan Kamel M Saad, Wan Rohani Wan Taib, Azly Sumanty Ab Ghani

|Sep 23, 2022
Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells.

Futoon Abedrabbu Al-Rawashde, Abdullah Saleh Al-Wajeeh, Mansoureh Nazari Vishkaei

|Jan 21, 2022
Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients.

Hanan Kamel M Saad, Alawiyah Awang Abd Rahman, Azly Sumanty Ab Ghani

|Dec 28, 2021
Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal SHP-1 and SOCS-3 Hypermethylation: In Vitro and In Silico Evaluation.

Futoon Abedrabbu Al-Rawashde, Muhammad Farid Johan, Wan Rohani Wan Taib

Pageof 1